BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 26172225)

  • 1. Development of Small-Molecule Antivirals for Ebola.
    Janeba Z
    Med Res Rev; 2015 Nov; 35(6):1175-94. PubMed ID: 26172225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Will There Be a Cure for Ebola?
    Cardile AP; Warren TK; Martins KA; Reisler RB; Bavari S
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():329-348. PubMed ID: 27959624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Marburg and Ebola hemorrhagic fevers--pathogens, epidemiology and therapy].
    Stock I
    Med Monatsschr Pharm; 2014 Sep; 37(9):324-30; quiz 331-2. PubMed ID: 25282746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ebola : an uncontrolled outbreak despite vaccines and new treatments].
    Vetter P; Kaiser L
    Rev Med Suisse; 2020 Apr; 16(690):739-743. PubMed ID: 32301308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of chemically synthesized inhibitors of Ebola virus.
    Cardile AP; Mayers DL; Bavari S
    Recent Pat Antiinfect Drug Discov; 2014; 9(2):97-103. PubMed ID: 25808170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of ebola virus disease.
    Kilgore PE; Grabenstein JD; Salim AM; Rybak M
    Pharmacotherapy; 2015 Jan; 35(1):43-53. PubMed ID: 25630412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current status of drug treatment against the disease caused by the Ebola virus].
    Reina J
    Rev Esp Quimioter; 2016 Feb; 29(1):1-7. PubMed ID: 26785224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ebola vaccine and treatment].
    Takada A
    Uirusu; 2015; 65(1):61-70. PubMed ID: 26923959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ebola virus (EBOV) infection: Therapeutic strategies.
    De Clercq E
    Biochem Pharmacol; 2015 Jan; 93(1):1-10. PubMed ID: 25481298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral therapeutics for the treatment of Ebola virus infection.
    Cardile AP; Downey LG; Wiseman PD; Warren TK; Bavari S
    Curr Opin Pharmacol; 2016 Oct; 30():138-143. PubMed ID: 27639220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [113th Scientific Meeting of the Japanese Society of Internal Medicine: Educational Lecture: Ebola Virus Disease: The Largest Ever Recorded Outbreak in West Africa].
    Kato Y
    Nihon Naika Gakkai Zasshi; 2016 Sep; 105(9):1803-8. PubMed ID: 30170343
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of Potential Small Molecule Therapeutics for Treatment of Ebola Virus Disease.
    Schafer A; Cheng H; Lee C; Du R; Han J; Perez J; Peet N; Manicassamy B; Rong L
    Curr Med Chem; 2018; 25(38):5177-5190. PubMed ID: 29032747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scale up the supply of experimental Ebola drugs.
    Brady O
    Nature; 2014 Aug; 512(7514):233. PubMed ID: 25143079
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions.
    Bausch DG; Sprecher AG; Jeffs B; Boumandouki P
    Antiviral Res; 2008 Apr; 78(1):150-61. PubMed ID: 18336927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A viewpoint on European Medicines Agency experience with investigational medicinal products for Ebola.
    Cavaleri M; Thomson A; Salmonson T; Hemmings RJ
    Clin Trials; 2016 Feb; 13(1):101-4. PubMed ID: 26768561
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor.
    Cheng H; Schafer A; Soloveva V; Gharaibeh D; Kenny T; Retterer C; Zamani R; Bavari S; Peet NP; Rong L
    Antiviral Res; 2017 Sep; 145():24-32. PubMed ID: 28645623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress on the treatment of Ebola virus disease with Favipiravir and other related strategies.
    Zhang T; Zhai M; Ji J; Zhang J; Tian Y; Liu X
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2364-2368. PubMed ID: 28462833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favipiravir: a new medication for the Ebola virus disease pandemic.
    Nagata T; Lefor AK; Hasegawa M; Ishii M
    Disaster Med Public Health Prep; 2015 Feb; 9(1):79-81. PubMed ID: 25544306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and Mayinga.
    Chiramel AI; Banadyga L; Dougherty JD; Falzarano D; Martellaro C; Brees D; Taylor RT; Ebihara H; Best SM
    J Infect Dis; 2016 Oct; 214(suppl 3):S355-S359. PubMed ID: 27511894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug targets in infections with Ebola and Marburg viruses.
    Gene OG; Julia BE; Vanessa MR; Victoria WJ; Thomas GW; Lisa HE
    Infect Disord Drug Targets; 2009 Apr; 9(2):191-200. PubMed ID: 19275706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.